Dr. Hans Hammers M.D., PH.D.
Oncologist | Medical Oncology
1550 Orleans St Crb I - 1m42 Baltimore MD, 21231Rating
5/5
About
Dr. Hans Hammers is an oncologist practicing in Baltimore, MD. Dr. Hammers specializes in the care and treatment of patients with cancer. As an oncologist, Dr. Hammers manages and oversees the treatment of a cancer patient after he or she has been diagnosed with the disease. Oncologists will care for their patients throughout the course of the disease. Types of oncologists include medical oncologists, surgical oncologists, radiation oncologists, gynecologic oncologists, pediatric oncologists and hematologist oncologists.
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM- Medical Oncology
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Differential expression of the B cell-restricted molecule CD22 on neonatal B lymphocytes depending upon antigen stimulation.
- Ultraviolet-induced detection of halogenated pyrimidines: simultaneous analysis of DNA replication and cellular markers.
- Improvement of the precision in CFU-GM and BFU-E counting by flow cytometry-based standardization of short-term culture assays.
- Introduction of a novel proliferation assay for pharmacological studies allowing the combination of BrdU detection and phenotyping.
- Identification and characterization of a very low density lipoprotein receptor-binding peptide from tissue factor pathway inhibitor that has antitumor and antiangiogenic activity.
- Withaferin A is a potent inhibitor of angiogenesis.
- Ultraviolet-induced detection of halogenated pyrimidines (UVID).
- Reversible epithelial to mesenchymal transition and acquired resistance to sunitinib in patients with renal cell carcinoma: evidence from a xenograft study.
- Screening assay for blood vessel maturation inhibitors.
- Nivolumab for Metastatic Renal Cell Carcinoma: Results of a Randomized Phase II Trial.
- Safety and clinical activity of vascular endothelial growth factor receptor (VEGFR)-tyrosine kinase inhibitors after programmed cell death 1 inhibitor treatment in patients with metastatic clear cell renal cell carcinoma.
- Evaluation of a novel mononuclear cell isolation procedure for serological HLA typing.
- Evaluation of a flow cytometric method for simultaneous leukocyte phenotyping and quantification by fluorescent microspheres.
Clinical Trials
Dr. Hans Hammers M.D., PH.D.'s Practice location
Dr. Hans Hammers M.D., PH.D.'s reviews
Write ReviewPatient Experience with Dr. Hammers
Recommended Articles
![]()
California Judge Reverses $417 Million Lawsuit Against Johnson & JohnsonFor a long time, Johnson & Johnson had been accused of not properly labeling their products. Namely, they have many products that contain a substance known as talc, which may carry risks for cancer. A few months back, a woman with ovarian cancer filed a lawsuit against the American-based,...
![]()
What is Compartment Syndrome?Compartment syndrome refers to the excessive buildup of pressure within the muscle compartments of the body. This will affect the functioning of the nerves and lead to cell death based on the intensity and duration of the pressure built up. Bleeding and inflammation after an injury usually leads to...
![]()
What Are Lymphocytes? Low, Normal, and High Lymphocyte CountsLymphocytes are a type of white blood cell produced in the bone marrow. A few lymphocytes enter the bloodstream while some move into the lymphatic system. Having a low or high lymphocyte count can help identify a person's medical condition. Normal lymphocyte counts usually vary from one laboratory...
![]()
What OB-GYNs Wish Their Patients Knew about Ovarian CancerThere are numerous things OB-GYN providers want their patients to know about ovarian cancer.For instance, that it is somewhat rare, but deadly. It ranks 5th in cancer deaths among women. Due primarily to the diagnostic issues noted below, about 70% of women are unfortunately in the most advanced...
![]()
Breast Cancer Death Rate Has Dropped Dramatically in the USThe results from a 2015 breast cancer study are in, and the news is great!The study shows there is a 39% lower death rate in the US from breast cancer. And that there has been a steady decline of such deaths since 1989. The reduction in breast cancer-related deaths is reported to be the result of...
![]()
How Your Father’s Genes Can Affect Your Ovarian Cancer RiskIt is well known that inherited mutations in BRCA1/BRCA2 genes increase the risk of breast and ovarian cancers, as well as other types of cancer. An altered mutation in the BRCA1 or BRCA2 gene can be inherited from an individual’s mother or father. ...
Nearby Providers
![]()
Dr. Johann Brandes MD, PHD1650 Orleans Street Baltimore MD 21231![]()
Dr. Channing Paller M.D.401 N. Broadway Baltimore MD 21231![]()
Dr. Julie Brahmer M.D.401 North Broadway Baltimore Maryland 21231![]()
Dr. Stephanie Louise Gaillard MD, PHD401 N BROADWAY BALTIMORE MD 21231![]()
Dr. David Peter Cosgrove M.D.401 N. Broadway Baltimore MD 21231![]()
Dr. Zeshaan Rasheed M.D., PHD.1650 Orleans St Baltimore MD 21231
Nearest Hospitals
JOHNS HOPKINS HOSPITAL, THEl
600 NORTH WOLFE STREET BALTIMORE MD 21287KENNEDY KREIGER INSTITUTEl
707 NORTH BROADWAY BALTIMORE MD 21205PARKLAND HEALTH AND HOSPITAL SYSTEMl
5200 HARRY HINES BLVD DALLAS TX 75235UT SOUTHWESTERN UNIVERSITY HOSPITAL-ZALE LIPSHYl
5151 HARRY HINES BLVD DALLAS TX 75390